# Proteinuria in Dogs and Cats: Diagnostic Approach and Clinical Significance ## Key Takeaways - The urine protein-to-creatinine ratio (UPC) is the gold standard for quantifying proteinuria in dogs and cats, with upper reference limits of approximately 0.2 and 0.33, respectively; dipstick analysis is unreliable, particularly in cats, due to poor agreement and susceptibility to false positives/negatives. - Persistent proteinuria, defined as two or more elevated UPC measurements over at least two weeks, is crucial for distinguishing clinically significant disease from transient physiologic proteinuria, which can occur with fever, stress, or exercise. - Localization of proteinuria is essential, with an active urine sediment (hematuria, pyuria, bacteriuria) suggesting a postrenal or lower urinary tract source, while an inactive sediment points towards a renal origin. - Glomerular proteinuria typically presents with marked elevations in UPC (often >2.0 in dogs, >1.0 in cats) and may necessitate further investigation for immune-mediated diseases, amyloidosis, or infectious agents like tick-borne pathogens. - Tubular proteinuria is generally mild (UPC usually <2.0) and results from impaired proximal tubular reabsorption of low-molecular-weight proteins, often associated with acute tubular injury or chronic interstitial nephritis. - Serial UPC measurements, alongside blood pressure monitoring, are critical for staging chronic kidney disease, assessing treatment response, and documenting disease progression, with values above 3.5 in conjunction with hypoalbuminemia often indicating a need for renal biopsy. --- Proteinuria is one of the most frequently identified abnormalities on routine urinalysis in companion animal practice, yet its clinical interpretation remains a source of diagnostic uncertainty. This article provides a systematic framework for the evaluation of proteinuria in dogs and cats, covering quantification methods, localization of the source, and the clinical significance of persistent proteinuria across the spectrum of renal and non-renal disease. The intended reader is the practicing veterinarian who needs a defensible, evidence-based approach to deciding which proteinuric patients require further investigation, how to interpret urine protein-to-creatinine ratio (UPC) results, and when proteinuria should alter diagnostic and monitoring plans. Specific treatment of underlying diseases is outside the scope of this article. The diagnostic challenge posed by proteinuria is that it is a laboratory finding, not a diagnosis. It may represent a benign and transient physiologic response, an early marker of progressive glomerular disease, a consequence of tubular injury, or a reflection of lower urinary tract inflammation or hemorrhage. The clinical significance of proteinuria depends on its magnitude, persistence, and source, and these three parameters must be established before any therapeutic or prognostic decisions are made. This article proceeds from the physiologic basis of protein handling by the kidney through the practical steps of quantification and localization, and concludes with guidance on clinical decision-making and monitoring. ## At a Glance | Parameter | Key Fact | Clinical Implication | |---|---|---| | Urine dipstick protein | Detects albumin predominantly, poor agreement with UPC in cats | Do not rely on dipstick alone for proteinuria diagnosis | | UPC reference interval | Upper limit approximately 0.2 in dogs, 0.33 in cats | Values above these thresholds warrant investigation | | Borderline proteinuria | UPC 0.2 to 0.4 | Repeat measurement and consider source localization | | Persistent proteinuria | Two or more positive samples over 2 or more weeks | Distinguishes clinically significant from transient proteinuria | | Renal proteinuria | UPC greater than 2.0 suggests glomerular disease | Renal biopsy may be indicated for prognostication | | Postrenal proteinuria | Active sediment, hematuria, pyuria, or bacteriuria present | Localize to lower urinary tract before renal workup | | Physiologic proteinuria | Transient, resolves with rest or stress reduction | Repeat testing after 2 to 4 weeks | ## Physiology of Renal Protein Handling The glomerular filtration barrier is a size-selective and charge-selective sieve composed of the fenestrated endothelium, the glomerular basement membrane, and the podocyte slit diaphragm. Albumin, with a molecular weight of approximately 69 kDa and a net negative charge, is largely excluded from the ultrafiltrate. The small fraction of albumin and low-molecular-weight proteins that do cross the barrier are reabsorbed by receptor-mediated endocytosis in the proximal tubular epithelium, principally via megalin and cubilin. The healthy kidney therefore excretes only trace amounts of protein, and the normal urine protein composition reflects this balance: a mixture of filtered low-molecular-weight proteins, secreted proteins such as uromodulin, and minimal albumin. Proteinuria develops when one or more of these mechanisms fails. Glomerular proteinuria results from disruption of the filtration barrier, allowing intermediate and high-molecular-weight proteins to enter the ultrafiltrate in quantities that overwhelm tubular reabsorptive capacity. Tubular proteinuria occurs when proximal tubular reabsorption is impaired, leading to excretion of low-molecular-weight proteins that would normally be reclaimed. Overflow proteinuria, less common in dogs and cats, arises when plasma concentrations of filterable proteins exceed the tubular threshold. Postrenal proteinuria originates distal to the kidney, from inflammation, hemorrhage, or exudation in the ureters, bladder, urethra, or genital tract. The distinction between glomerular and tubular proteinuria has diagnostic value, but in practice the magnitude of proteinuria is the more clinically useful discriminator. Glomerular disease typically produces marked proteinuria with UPC values frequently exceeding 2.0, whereas tubular disease rarely produces UPC values above 1.0. This separation is not absolute, and advanced chronic kidney disease (CKD) with tubulointerstitial damage can produce mixed patterns. The clinical significance of proteinuria in CKD is well established: proteinuria is both a marker of glomerular injury and an independent driver of progressive tubulointerstitial fibrosis, as filtered proteins in the tubular lumen provoke inflammatory and fibrotic cascades. ## Quantification of Proteinuria ### Urine Dipstick Analysis The urine dipstick is the most commonly used screening test for proteinuria, but its limitations are substantial. The dipstick reagent is most sensitive to albumin and detects other proteins poorly. It is subject to false-positive results in alkaline urine, concentrated urine, and samples containing hemoglobin, myoglobin, or contrast agents. Conversely, dilute urine can produce false-negative results. A study of 121 feline urine samples found poor diagnostic agreement between dipstick protein results and UPC, with a dipstick reading of trace or greater showing a sensitivity of 81% and a specificity of only 31% for detecting proteinuria as defined by UPC. Grouping samples by urine specific gravity did not meaningfully improve this agreement. The authors concluded that clinicians should not rely on dipstick testing for proteinuria detection in cats, regardless of urine concentration, and should use quantitative methods such as UPC instead. The same principle applies to dogs, although the published evidence base is less robust. ### Urine Protein-to-Creatinine Ratio The UPC ratio is the recommended quantitative method for assessing proteinuria in dogs and cats. It corrects for urine concentration by expressing protein excretion relative to creatinine excretion in a single voided or cystocentesis sample. The ratio is stable across the day in stable patients, making a single sample adequate for initial assessment. The upper limit of the reference interval is approximately 0.2 in dogs and 0.33 in cats, with the feline value derived from a 1990 study of 19 healthy cats that established the upper limit as the mean plus two standard deviations. Values between 0.2 and 0.4 in cats are considered borderline proteinuria, and values above 0.4 are classified as proteinuric. The UPC ratio has limitations that the clinician must recognize. It does not distinguish between albumin and other proteins, so a high ratio in the presence of hematuria or pyuria may reflect postrenal contamination instead of renal disease. It is also affected by extremes of urine concentration, although this effect is modest within the physiologic range. Serial UPC measurements are the standard method for monitoring progression of proteinuria and response to therapy, and the International Renal Interest Society (IRIS) staging system for CKD incorporates UPC as a key prognostic variable. ## Localization of Proteinuria Once proteinuria is confirmed quantitatively, the next step is localization. The urine sediment examination is the critical first discriminator. An inactive sediment with no hematuria, pyuria, or bacteriuria supports a renal origin for the proteinuria. An active sediment, particularly with dysmorphic red blood cells, white blood cells, or casts, raises the possibility of postrenal or inflammatory contributions. In a study of captive nondomestic felids undergoing routine health checks, 49% of animals had proteinuria or borderline proteinuria, and among these, 62% were classified as renal in origin and 38% as postrenal, underscoring the frequency with which postrenal sources confound proteinuria interpretation. The distinction between glomerular and tubular proteinuria can be refined by protein electrophoresis or measurement of specific proteins such as albumin and retinol-binding protein, but these assays are not widely available in clinical practice. In most cases, the combination of UPC magnitude, urine sediment findings, and systemic blood pressure assessment provides sufficient localization for clinical decision-making. ## Diagnostic Algorithm for Proteinuria The diagnostic approach to proteinuria proceeds through three sequential decisions: confirmation, localization, and clinical interpretation. Each step changes the differential list and the urgency of further investigation. ### Step 1: Confirm Persistent Proteinuria A single proteinuric sample does not establish renal disease. Transient proteinuria accompanies fever, seizures, exercise, stress, and hypotension. The recommended sequence is to repeat the UPC measurement on two or more samples collected at intervals of 2 to 4 weeks. Persistent proteinuria is defined as two or more elevated measurements across separate visits. The urine sediment must be examined at every step. Hematuria, pyuria, and bacteriuria each contribute protein to the sample and invalidate UPC interpretation. If active sediment is present, the proteinuria should be reassessed after the underlying urinary tract disease is treated. In cats, the dipstick test performs poorly against the UPC ratio as the reference method, and grouping results by urine specific gravity does not meaningfully improve agreement, so the UPC should be used whenever quantification matters [Pérez-Accino et al., dipstick and specific gravity in feline proteinuria](https://pubmed.ncbi.nlm.nih.gov/32692434/). ### Step 2: Localize the Source Localization separates prerenal, renal, and postrenal proteinuria. The urine sediment is the first discriminator. Postrenal proteinuria is suspected when sediment shows erythrocytes, leukocytes, bacteria, or casts originating from the lower tract. Renal proteinuria is suggested by an inactive sediment with persistent proteinuria, and glomerular versus tubular origin is inferred from magnitude and progression. | Finding | Likely localization | Next step | |---|---|---| | Active sediment, hematuria, pyuria | Postrenal or lower urinary tract | Culture, imaging, reassess after treatment | | Inactive sediment, UPC 0.5 to 2.0 | Tubular or early glomerular | Repeat UPC, blood pressure, biochemistry | | Inactive sediment, UPC greater than 2.0 | Glomerular | Consider biopsy, screen for infectious and inflammatory causes | | UPC greater than 3.5 with hypoalbuminemia | Glomerular with protein-losing nephropathy | Aggressive workup, consider biopsy | In captive nondomestic felids undergoing routine health checks, proteinuria or borderline proteinuria was found in 49% of animals, with 62% of those cases of renal origin and 38% postrenal, which illustrates that even in asymptomatic patients a substantial fraction of proteinuria is not renal and requires sediment examination before further testing [Rauch-Schmücking et al., cystocentesis and urinalysis in large felid health checks](https://pubmed.ncbi.nlm.nih.gov/39255196/). ### Step 3: Interpret the Magnitude The UPC ratio provides the quantitative basis for staging and monitoring. In cats, the upper reference limit has been established at 0.33, and the ratio is reliable for diagnosing proteinuria in uremic patients, although only very high values allow conclusions about the type of nephropathy while moderately increased values do not distinguish between feline nephropathies [Hörauf et al., protein-creatinine ratio in feline nephropathies](https://pubmed.ncbi.nlm.nih.gov/2219113/). For clinical purposes, the International Renal Interest Society (IRIS) staging system is widely used. A UPC below 0.2 is considered nonproteinuric, 0.2 to 0.4 is borderline in cats, and above 0.4 is proteinuric. In dogs, a UPC above 0.5 is proteinuric, and values above 2.0 raise strong suspicion of glomerular disease. These thresholds guide monitoring frequency and the decision to pursue renal biopsy. ## Causes of Pathologic Proteinuria ### Glomerular Disease Glomerular proteinuria results from damage to the filtration barrier. The magnitude is typically moderate to severe, with UPC values often exceeding 2.0. Causes include immune complex deposition, amyloidosis, and membranous nephropathy. In dogs, infectious and inflammatory triggers include borreliosis, anaplasmosis, and babesiosis, all of which can produce renal manifestations and should be considered in endemic regions [Pantchev et al., tick-borne diseases in dogs](https://pubmed.ncbi.nlm.nih.gov/26152408/). The diagnostic workup for suspected glomerular disease should include serology or PCR for vector-borne pathogens, blood pressure measurement, and a coagulation profile before biopsy. ### Tubular Disease Tubular proteinuria is typically mild, with UPC values usually below 2.0. The protein lost is predominantly low molecular weight, and the sediment may show granular casts. Causes include acute tubular injury, ischemia, nephrotoxins, and chronic interstitial nephritis. Tubular proteinuria does not cause hypoalbuminemia until advanced. ### Postrenal and Prerenal Contributions Postrenal proteinuria arises from inflammation or hemorrhage in the bladder, urethra, or genital tract. Prerenal proteinuria results from overflow of abnormal plasma proteins, such as Bence Jones proteins in myeloma, and is uncommon in small animal practice. ## Monitoring and Documentation Serial UPC measurement is the standard method for tracking disease progression and response to intervention. The same laboratory and method should be used for serial comparisons because interlaboratory variation can confound trend interpretation. Blood pressure should be measured at each recheck because hypertension both causes and results from renal proteinuria. Documentation should record the UPC value, urine specific gravity, sediment findings, blood pressure, and serum creatinine or symmetric dimethylarginine at each visit. In felids, serum kidney markers correlate negatively with urine specific gravity, which reinforces the need to assess both parameters together during kidney evaluations [Rauch-Schmücking et al., cystocentesis and urinalysis in large felid health checks](https://pubmed.ncbi.nlm.nih.gov/39255196/). ## Species and Context Modifications The approach differs by species and clinical context. In cats, borderline proteinuria (UPC 0.2 to 0.4) warrants monitoring but not immediate intervention. In dogs, the same range is considered normal. In nondomestic felids, cystocentesis under general anesthesia is feasible during routine health checks and provides valuable staging information that serum markers alone cannot offer [Rauch-Schmücking et al., cystocentesis and urinalysis in large felid health checks](https://pubmed.ncbi.nlm.nih.gov/39255196/). In patients with active sediment, treatment of the urinary tract infection or inflammation takes priority, and the UPC should be repeated 2 to 4 weeks after resolution. In azotemic patients, the UPC helps distinguish prerenal from renal azotemia and guides fluid therapy decisions. In nonazotemic patients, persistent proteinuria may be the earliest indicator of chronic kidney disease and should trigger blood pressure measurement and staging. When the UPC is borderline and clinical suspicion remains high, repeat measurement is more useful than proceeding directly to biopsy. When the UPC exceeds 3.5 with hypoalbuminemia and an inactive sediment, renal biopsy is indicated to distinguish treatable immune-mediated disease from amyloidosis, provided coagulation status and blood pressure permit. The decision to biopsy should also account for the patient's age, comorbidities, and the owner's willingness to pursue immunosuppressive therapy, since the biopsy result changes management only when treatment will be adjusted accordingly. Laboratory quality assurance matters throughout. Reference intervals and method validation should follow established clinical pathology standards, and serial samples should be processed by the same laboratory to minimize method-related variation [ASVCP quality assurance guidelines](https://www.asvcp.org/page/QALS_Guidelines). ## Recognized Complications and Failure Modes Persistent proteinuria that escapes detection or is misclassified carries the principal risk of delayed intervention for progressive glomerular disease. The most consequential failure mode is the false-negative dipstick result in dilute urine. Dipstick colorimetric methods depend on urine concentration, and a negative result in a hyposthenuric sample does not exclude clinically relevant protein loss. Conversely, a false-positive dipstick result in highly concentrated or alkaline urine prompts unnecessary investigation. The [combined use of dipstick and urine specific gravity does not reliably predict feline proteinuria](https://pubmed.ncbi.nlm.nih.gov/32692434/), so quantitative measurement by UPC remains the arbiter whenever the dipstick is positive or clinical suspicion is high. A second failure mode is the interpretation of a single UPC measurement without accounting for prerenal or postrenal contamination. Hematuria, pyuria, and bacteruria each contribute protein that is not of renal origin. A single elevated UPC in a patient with active sediment should be repeated after the sediment abnormality resolves. In captive nondomestic felids undergoing health checks, [postrenal causes accounted for 38% of proteinuric cases](https://pubmed.ncbi.nlm.nih.gov/39255196/), a reminder that localization is mandatory before attributing proteinuria to the kidney. A third failure mode is the assumption that proteinuria magnitude alone distinguishes glomerular from tubular disease. Marked proteinuria with UPC above 2.0 in dogs or above 1.0 in cats strongly suggests glomerular disease, but moderate elevations overlap substantially between categories. Historical data in cats show that [only very high UPC values permit conclusions about the type of nephropathy](https://pubmed.ncbi.nlm.nih.gov/2219113/), while moderately increased values do not. The clinician who skips localization studies, such as urine protein electrophoresis or fractional clearance of low-molecular-weight proteins, risks misclassifying the lesion. ## Common Errors and Corrective Actions Less experienced clinicians frequently overinterpret the dipstick trace result. A trace reading has high sensitivity but poor specificity for true proteinuria, and acting on it without UPC confirmation generates false alarms. The corrective action is to treat the dipstick as a screening test only and to quantify with UPC before initiating a diagnostic workup. A related error is failure to correct for urine concentration when interpreting UPC. The ratio already normalizes for concentration, so no correction is needed, but clinicians sometimes apply a dipstick-based correction factor instead. This practice has no basis and should be abandoned. The [ASVCP quality assurance guidelines](https://www.asvcp.org/page/QALS_Guidelines) emphasize that method validation and reference intervals must be established for the specific laboratory and instrument in use, and this applies equally to UPC methodology. Another common error is pursuing exhaustive renal investigation in a patient with transient, stress-associated proteinuria. Cats, in particular, may show mild proteinuria that resolves on recheck. The diagnostic algorithm requires confirmation of persistence across at least two samples before proceeding to advanced imaging or biopsy. ## Limitations of Current Evidence The evidence base for UPC thresholds derives largely from cross-sectional studies with modest sample sizes. The upper reference limit in cats was established from 19 healthy animals, a small cohort by modern standards, and the [original work itself cautioned that moderate elevations do not discriminate between nephropathies](https://pubmed.ncbi.nlm.nih.gov/2219113/). Reference intervals vary between laboratories, and the [ASVCP guidelines](https://www.asvcp.org/page/QALS_Guidelines) recommend that each laboratory verify or establish its own intervals instead of adopt published values uncritically. Expert opinion diverges on the optimal frequency of UPC monitoring in stable CKD patients. Some nephrologists advocate quarterly measurement, while others monitor biannually unless the trend is rising. Neither position is supported by prospective outcome data. Similarly, the prognostic value of UPC reduction in response to therapy is inferred from human medicine and experimental models instead of from large veterinary trials. The [macrophage proliferation observed in aggressive human glomerulonephritis](https://pubmed.ncbi.nlm.nih.gov/9648072/) illustrates the inflammatory amplification that proteinuria may reflect, but direct extrapolation of human histopathologic staging to veterinary patients is not validated. ## Referral and Escalation Criteria Referral to a specialist is warranted when proteinuria is persistent, magnitude is high, or renal function is declining despite initial management. Specific triggers include UPC above 2.0 in dogs, UPC above 1.0 in cats, progressive azotemia, hypoalbuminemia, or development of hypertension or thromboembolic complications. Renal biopsy should be considered when the distinction between glomerular and tubular disease affects therapy or prognosis, and this procedure is best performed by experienced operators. Laboratory involvement is appropriate when results are discordant between methods, when reference interval questions arise, or when specialized testing such as protein electrophoresis or fractional clearance is needed. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) provides species-specific guidance on test interpretation that can support clinical decisions in these situations. Regulatory reporting obligations vary by jurisdiction and by the suspected cause. Where infectious agents with public health significance are suspected, such as certain tick-borne pathogens that cause proteinuria as part of systemic disease, [regional diagnostic algorithms and surveillance frameworks](https://pubmed.ncbi.nlm.nih.gov/26152408/) may apply. The [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) define notification requirements for listed diseases, and the [AVMA practice resources](https://www.avma.org/resources-tools) can clarify professional obligations in the United States. Clinicians should confirm local requirements instead of assume a uniform standard. ## Troubleshooting Table | Observation | Likely Cause | Discriminating Check | |---|---|---| | Negative dipstick, dilute urine | False negative due to low concentration | Measure UPC, do not rely on dipstick | | Positive dipstick, concentrated urine | False positive or true proteinuria | Confirm with UPC, check pH and sediment | | Elevated UPC with hematuria | Postrenal contamination | Repeat after sediment clears, consider cystocentesis | | Elevated UPC in a cat, single sample | Stress-associated or transient | Repeat in 2 to 4 weeks before workup | | UPC elevated but serum creatinine normal | Early glomerular disease | Measure blood pressure, albumin, SDMA | | Discordant UPC between laboratories | Method or calibration differences | Verify with the [ASVCP laboratory standards](https://www.asvcp.org/page/QALS_Guidelines) | ## Frequently Asked Questions ### How should I proceed when a urine protein-to-creatinine ratio is not immediately available? When same-day UPC measurement is unavailable, submit an appropriately collected urine sample to a commercial laboratory for assay within 24 to 48 hours. Refrigerate the sample if transport is delayed. In the interim, use the dipstick result only as a screening tool, and interpret it with caution. The dipstick shows poor diagnostic agreement with the UPC in cats, and grouping results by urine specific gravity does not meaningfully improve accuracy, so a positive dipstick should not be treated as confirmation of proteinuria and a negative dipstick does not exclude it. Document the provisional nature of the dipstick finding in the medical record and plan confirmatory testing before initiating diagnostic or therapeutic decisions based on proteinuria. ### What does proteinuria mean in a non-domestic felid or exotic carnivore? The same pathophysiologic framework applies across felid species. In captive non-domestic felids undergoing routine health checks, proteinuria with UPC greater than 0.4 or borderline proteinuria between 0.2 and 0.4 was identified in approximately half of animals examined, with renal causes accounting for 62% of cases and postrenal causes for 38%. Urine specific gravity was significantly higher in felids with borderline proteinuria compared with those meeting the proteinuric threshold, and serum kidney markers correlated negatively with urine concentration. These findings support routine urinalysis with UPC measurement during health assessments in large felids, since chronic kidney disease may remain asymptomatic for years and early detection depends on active screening. ### How do I distinguish transient proteinuria from persistent proteinuria in a single outpatient visit? A single urine sample cannot establish persistence. Repeat urine collection within 2 to 4 weeks before classifying the patient as proteinuric. If the initial sample was collected after exercise, transport, stress, or a febrile episode, repeat sooner. Transient proteinuria from physiologic causes typically resolves on recheck. Persistent proteinuria, defined as two or more abnormal samples over 2 or more weeks, warrants localization and staging. In a patient with known systemic disease such as tick-borne infection, proteinuria may reflect active glomerular injury and should be monitored alongside the primary disease process instead of dismissed as incidental. ### What is the minimum database I should obtain before referring a proteinuric patient? Perform a complete urinalysis with sediment examination, UPC, serum biochemistry including creatinine and albumin, and blood pressure measurement. A urine culture should be obtained when sediment abnormalities suggest infection or when postrenal proteinuria is suspected. Symmetric dimethylarginine adds value in cats when creatinine remains within reference limits despite reduced functional mass. If these results indicate glomerular disease, consider infectious disease screening appropriate to the region, including vector-borne pathogens, before referral. Refer when proteinuria is severe, when azotemia progresses despite management, when hypoalbuminemia develops, or when the diagnostic plan exceeds your practice resources. Provide the referring clinician with all raw data and the dates of sample collection. ### How should I document proteinuria in the medical record for longitudinal monitoring? Record the collection method, urine specific gravity, dipstick reading, and UPC value with the date and time for every sample. Note the patient's blood pressure, body weight, and current medications at each assessment, since these variables influence protein excretion. Use the same laboratory for serial UPC measurements to minimize inter-laboratory variation, and follow quality assurance standards for clinical pathology testing. Document the clinical decision threshold applied, for example the International Renal Interest Society staging system, and record the trend explicitly, such as stable, improving, or worsening. This documentation supports treatment decisions, client communication, and referral communication. ### How do I explain proteinuria to a client without causing undue alarm? Explain that the kidney normally holds protein in the blood and that finding protein in urine can indicate kidney filter damage, inflammation, or bleeding somewhere in the urinary tract. State that a single finding is not a diagnosis and that repeat testing is needed to confirm the problem is persistent. Describe the next steps in plain terms: another urine test, a blood test, and blood pressure measurement. Avoid prognostic statements until staging is complete. For species where reference intervals differ, such as non-domestic felids, acknowledge that interpretation relies on extrapolation from domestic species and that published data support the same diagnostic approach. Reassure the client that early detection allows monitoring and intervention before clinical signs develop. ## Related Clinical & Scientific Guides * [Peripheral Blood Smear Evaluation: A Step-by-Step Guide](/knowledge/veterinary-medicine/clinical-pathology/peripheral-blood-smear-evaluation-guide) * [Reticulocyte Counts in Veterinary Medicine: Clinical Utility and Interpretation](/knowledge/veterinary-medicine/clinical-pathology/reticulocyte-counts-veterinary-medicine) * [Cerebrospinal Fluid Analysis in Veterinary Neurology: Collection and Interpretation](/knowledge/veterinary-medicine/clinical-pathology/cerebrospinal-fluid-analysis-veterinary) ## References and Further Reading - [CYSTOCENTESIS AND URINALYSIS IN ZOOMEDICINE: AN UNDERESTIMATED TOOL FOR LARGE FELID STANDARD HEALTH CHECKS.](https://pubmed.ncbi.nlm.nih.gov/39255196/). 2024. - [The utility of combined urine dipstick analysis and specific gravity measurement to determine feline proteinuria.](https://pubmed.ncbi.nlm.nih.gov/32692434/). 2020. - [[The diagnostic significance of the protein-creatinine ratio in urine for the differentiation of feline nephropathies].](https://pubmed.ncbi.nlm.nih.gov/2219113/). 1990. - [Tick-borne Diseases (Borreliosis, Anaplasmosis, Babesiosis) in German and Austrian Dogs: Status quo and Review of Distribution, Transmission, Clinical Findings, Diagnostics and Prophylaxis.](https://pubmed.ncbi.nlm.nih.gov/26152408/). 2015. - [Utility of Recombinant Schistosoma bovis 22.6 kDa Antigen for Diagnosis of Human Urogenital Schistosomiasis by an Enzyme-Linked Immunosorbent Assay](https://doi.org/10.21203/rs.3.rs-7967904/v1). 2025. - [Local macrophage proliferation in human glomerulonephritis.](https://pubmed.ncbi.nlm.nih.gov/9648072/). 1998. - [American Society for Veterinary Clinical Pathology Guidelines](https://www.asvcp.org/page/QALS_Guidelines). American Society for Veterinary Clinical Pathology. - [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual. - [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association. ## Related Articles - [Thrombocytopenia in Dogs and Cats: Diagnostic Approach and Differential Prioritization](/knowledge/veterinary-medicine/clinical-pathology/thrombocytopenia-dogs-cats-diagnostic) - [Leukogram Patterns in Dogs and Cats: A Diagnostic Guide](/knowledge/veterinary-medicine/clinical-pathology/leukogram-patterns-dogs-cats) - [Cytology of Cutaneous and Subcutaneous Masses: A Diagnostic Approach](/knowledge/veterinary-medicine/clinical-pathology/cytology-cutaneous-subcutaneous-masses) - [Monitoring Hepatic Enzyme Trends in Dogs and Cats: Clinical Significance](/knowledge/veterinary-medicine/clinical-pathology/monitoring-hepatic-enzyme-trends-dogs-cats-clinical-significance) - [Liver Enzyme Interpretation in Dogs and Cats: Beyond the Numbers](/knowledge/veterinary-medicine/clinical-pathology/liver-enzyme-interpretation-dogs-cats) > This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.